Lupeng Pharmaceutical Overview
- Year Founded
-
2018
- Status
-
IPO Registration
- Employees
-
85
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
12
Lupeng Pharmaceutical General Information
Description
Developer of molecule innovative drugs intended to treat various diseases. The company is engaged in the research and development of innovative molecular drugs for the treatment of tumors, hepatitis B and other severe health diseases, providing new innovative drugs for treating cancer and other diseases.
Contact Information
Website
www.lupengbio.comCorporate Office
- Room 616, Building B
- No. 33 Science Avenue, Huangpu District
- Guangzhou, Guangdong 510670
- China
Corporate Office
- Room 616, Building B
- No. 33 Science Avenue, Huangpu District
- Guangzhou, Guangdong 510670
- China
Lupeng Pharmaceutical Timeline
Lupeng Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. IPO | 06-Nov-2025 | Announced | Generating Revenue | |||
| 6. Secondary Transaction - Private | 01-Oct-2025 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 16-Nov-2022 | Completed | Clinical Trials - General | |||
| 4. Early Stage VC | 27-Sep-2022 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC | 02-Jun-2021 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A1) | 23-Jun-2020 | $23.9M | $23.9M | Completed | Clinical Trials - General | |
| 1. Early Stage VC (Series A) | 23-Jan-2019 | Completed | Clinical Trials - General |
Lupeng Pharmaceutical Comparisons
Industry
Financing
Details
Lupeng Pharmaceutical Competitors (46)
One of Lupeng Pharmaceutical’s 46 competitors is Incyte, a Formerly VC-backed company based in Wilmington, DE.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Incyte | Formerly VC-backed | Wilmington, DE | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Nexoplex bio | Formerly VC-backed | Emeryville, CA | ||||
| IASO Biotechnology | Venture Capital-Backed | Nanjing, China | ||||
| Brii Biosciences | Formerly VC-backed | Beijing, China |
Lupeng Pharmaceutical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lupeng Pharmaceutical Patents
Lupeng Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024320769-A1 | Crystal form vi of acrylamide compound, and preparation method therefor and use thereof | Pending | 07-Aug-2023 | ||
| EP-4759812-A1 | Crystal form vi of acrylamide compound, and preparation method therefor and use thereof | Pending | 07-Aug-2023 | ||
| WO-2025031344-A1 | Crystal form vi of acrylamide compound, and preparation method therefor and use thereof | Inactive | 07-Aug-2023 | ||
| WO-2023230059-A1 | Mdm2 degrader | Inactive | 24-May-2022 | ||
| WO-2023137225-A1 | Btk degrader | Inactive | 17-Jan-2022 | C07D519/00 |
Lupeng Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lupeng Pharmaceutical Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| OrbiMed | Growth/Expansion | Minority | ||
| Temasek Holdings | Sovereign Wealth Fund | Minority | ||
| Tencent Investment | Corporate Venture Capital | Minority | ||
| True Light Capital | Asset Manager | Minority | ||
| Lake Bleu Capital | Hedge Fund | Minority |
Lupeng Pharmaceutical FAQs
-
When was Lupeng Pharmaceutical founded?
Lupeng Pharmaceutical was founded in 2018.
-
Where is Lupeng Pharmaceutical headquartered?
Lupeng Pharmaceutical is headquartered in Guangzhou, China.
-
What is the size of Lupeng Pharmaceutical?
Lupeng Pharmaceutical has 85 total employees.
-
What industry is Lupeng Pharmaceutical in?
Lupeng Pharmaceutical’s primary industry is Drug Discovery.
-
Is Lupeng Pharmaceutical a private or public company?
Lupeng Pharmaceutical is a Private company.
-
What is Lupeng Pharmaceutical’s current revenue?
The current revenue for Lupeng Pharmaceutical is .
-
How much funding has Lupeng Pharmaceutical raised over time?
Lupeng Pharmaceutical has raised $195M.
-
Who are Lupeng Pharmaceutical’s investors?
OrbiMed, Temasek Holdings, Tencent Investment, True Light Capital, and Lake Bleu Capital are 5 of 12 investors who have invested in Lupeng Pharmaceutical.
-
Who are Lupeng Pharmaceutical’s competitors?
Incyte, Genentech, Nexoplex bio, IASO Biotechnology, and Brii Biosciences are some of the 46 competitors of Lupeng Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
